The mRNA from a cohort of 55 NSCLC patients followed in IPO-Lisboa was used to quantify the expression of CBS, CTH, MPST, GOT1, GOT2, CDO1, SLC1A1, and SLC7A11 genes. The gene discussed is CDO1; the disease is non-small cell lung carcinoma.